AI-Enabled Clinical Trial Engineering Framework
A systematic review proposed an AI-enabled clinical trial engineering framework that could reduce timelines and costs in clinical trials. It aims to accelerate the identification of effective therapies while eliminating ineffective ones.
- Tags
- #MSResearch
- Most relevant to
- —
Why it matters
The proposed framework addresses persistent challenges in traditional randomized controlled trials, potentially improving the efficiency of clinical research across various medical specialties.
What this does not prove
This review does not provide specific clinical trial results or efficacy of treatments, nor does it establish causation between the framework and improved trial outcomes.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Systematic review
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-09-10
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
Original sources
- Primary evidenceAI-enabled clinical trials. ↗DOI: 10.1038/s44222-026-00487-7
Supporting passages (6)
study phaseRandomized controlled trials remain the gold standard for evaluating the benefits and risks of new interventions, yet they face persistent challenges including high costs constraining sample sizes, complex eligibility criteria, recruitment difficulties, prolonged follow-up periods to capture hard end points, and the growing prevalence of poorly designed studies that create noise in literature.
study designThis Review proposes an artificial intelligence (AI)-enabled clinical trial engineering framework, applicable across medical specialties.
interventionThis Review proposes an artificial intelligence (AI)-enabled clinical trial engineering framework, applicable across medical specialties.
findingsAI-enabled clinical trials could shorten timelines, reduce costs and accelerate both the identification of effective therapies and the earlier elimination of futile ones.
publication datePublication date: 2026-09-10
limitationsTitle: AI-enabled clinical trials.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.